FindTrial
Sign In

Artikaiinin ja lidokaiinin vertailu diodilaserpotilaiden paraokulaaripuudutuksessa

Artikaiinin ja lidokaiinin vertailu diodilaserpotilaiden paraokulaaripuudutuksessa

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2008-002999-98-FI
Enrollment
Unknown
Registered
2008-05-21
Start date
2008-09-09
Completion date
Unknown
Last updated
2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Potilaille suoritetetaan silmäsairauden hoitamiseksi laserhoito, minkä kivuton suoritus vaatii silmäpuudutuksen (retrobulbaaripuudutus). Tavallisesti käytämme 2% lidokaiinia. Nyt vertaamme 2% lidokaiinin ja 2% artikaiinin puudutusvaikutusta.

Interventions

Trade Name: Lidocain 20 mg/ml Pharmaceutical Form: Trade Name: Ultracain 2% Product Name: Ultracain 2% Pharmaceutical Form: Solution for injection

Sponsors

Helena Kallio
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Main Objective: ;Secondary Objective: ;Primary end point(s):—

Countries

Finland

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026